valproic acid and raltegravir potassium

valproic acid has been researched along with raltegravir potassium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Archin, NM; Bosch, RJ; Cheema, M; Coffin, JM; Cohen, M; Eron, J; Margolis, DM; Parker, D; Wiegand, A	1

Trials

1 trial(s) available for valproic acid and raltegravir potassium

Article	Year
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PloS one, 2010, Feb-23, Volume: 5, Issue:2 Topics: Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Enfuvirtide; Enzyme Inhibitors; Histone Deacetylase Inhibitors; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Male; Peptide Fragments; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Treatment Outcome; Valproic Acid; Viremia	2010

Article

Year

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection.

PloS one, 2010, Feb-23, Volume: 5, Issue:2

Topics: Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Enfuvirtide; Enzyme Inhibitors; Histone Deacetylase Inhibitors; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Male; Peptide Fragments; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Treatment Outcome; Valproic Acid; Viremia

2010